Albumin Use in Patients With Cirrhosis in France: Results of the “ALBU-LIVE” Survey

Archive ouverte

Garioud, Armand | Cadranel, Jean-François | Pauwels, Arnaud | Nousbaum, Jean-Baptiste | Thévenot, Thierry | Dao, Thong | Louvet, Alexandre | Sogni, Philippe | Talbodec, Nathalie | Antonini, Teresa | Bureau, Christophe | Thabut, Dominique | Elkrief, Laure | Jouannaud, Vincent | Macaigne, Gilles | Bernard-Chabert, Brigitte | Lison, Hortensia | Alric, Laurent | Carbonell, Nicolas | Labadie, Héléne | Amiot, Xavier | Abergel, Armand | Hanslik, Bertrand | Leroy, Vincent | de Lédinghen, Victor | Denis, Jacques

Edité par CCSD ; Lippincott, Williams & Wilkins -

International audience. IntroductionThe use of human albumin for the management of cirrhosis has increased. Recommendations have been published for therapeutic paracentesis (TP), spontaneous bacterial peritonitis (SBP), and type 1 hepatorenal syndrome (HRS). The goal of this survey was to assess the prescription practices of French hepatogastroenterologists.MethodsAll hepatogastroenterologists were contacted. The questionnaire evaluated (1) the use of albumin in validated indications and (2) the prescription of albumin for nonvalidated clinical situations.ResultsResponses were analyzed from 451 (50.1%) practitioners. The mean age was 40 years (range, 24 to 67 y). Physicians practiced in a university hospital (47.7%) or a general hospital (45.8%). There were 56.7% senior practitioners. Overall 99.6% of the practitioners compensated for TP. Albumin was used by 87.8% of the physicians, with a fixed dose being used by 84.6%. For SBP, 94% of the physicians used albumin concomitantly with antibiotics. The recommended protocol was followed by 56.2% of the practitioners: more often by senior university hospital practitioners than by senior general hospital practitioners (P=0.015). About 66.5% used albumin infusion for the diagnosis of HRS: used more often by senior university hospital practitioners (P=0.0006). Albumin was used concomitantly with vasopressor treatment by 84%; the dose and the duration varied considerably. About 23.5% used albumin for severe bacterial infection, 47.9% for severe hyponatremia, 43.9% for severe hypoalbuminemia, and 65.9% for hydrothorax.ConclusionsIn this large French survey, albumin is only prescribed in accordance with recommendations for TP. The schedule for SBP is followed by only 56% of the practitioners. The use of albumin for HRS is not adapted to recommendations, which are not well known, suggesting that they should be more diffused.

Consulter en ligne

Suggestions

Du même auteur

Severe liver failure rather than cirrhosis is associated with mortality in patients with infectious endocarditis: a retrospective case-control study.

Archive ouverte | Allaire, Manon | CCSD

International audience

Severe liver failure rather than cirrhosis is associated with mortality in patients with infectious endocarditis: a retrospective case-control study.

Archive ouverte | Allaire, Manon | CCSD

International audience

Severe liver failure rather than cirrhosis is associated with mortality in patients with infectious endocarditis: a retrospective case-control study

Archive ouverte | Allaire, Manon | CCSD

International audience. Background: Data on infectious endocarditis (IE) in patients with liver cirrhosis (LC) are sparse. We aimed to describe the characteristics and predictors of mortality from IE in patients wit...

Chargement des enrichissements...